CBLL Q2 2025 Earnings — CeriBell, Inc. Revenue & Financial Results | Market Cap Arena

CBLLCeriBell, Inc.

$704M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$21M+42.7% YoY

Gross Profit

$19M88.1% margin

Operating Income

-$15M-70.5% margin

Net Income

-$14M-64.4% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+3.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$208M

Total Liabilities

$36M

Stockholders' Equity

$172M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$15M	+42.7%
Gross Profit	$19M	$13M	+46.5%
Operating Income	-$15M	-$8M	-77.1%
Net Income	-$14M	-$9M	-56.3%

Revenue Segments

Product

$16M75%

Subscription

$5M25%